美国AtriCure公司生产出双极软组织消融治疗仪

 
一种新型双极消融系统，能够帮助医生更加彻底地消融较厚的和病变更严重的组织，使得治疗效果更为持久。

Isolator Synergy双极消融系统，在夹子的狭口处有两个脉冲电极对，从而产生一致的全厚度消融柱状病变消融效果，这样在较厚和病变程度较重的组织能够进行更持久的消融效果。该系统的狭口较低，便于在病变周围组织安放和操作。临床前试验已经证实，该系统能够在较厚的组织产生一致的透壁消融效果。Isolator Synergy是美国AtriCure公司 (Cincinnati, OH, USA)的产品，已经得到了美国食品药品管理局(FDA)的批准，用于消融软组织。该设备还未获准用于心肌组织的消融治疗。

Bipolar Soft Tissue Ablation System
 
A new bipolar ablation system allows physicians to ensure full thickness ablation of thicker and more diseased tissues and create more durable lines of block.

The Isolator Synergy bipolar ablation system incorporates two pulsing pairs of electrodes in the jaws of the clamp, creating a uniform, full thickness ablation lesion shaped like a column, which results in more durable ablation lines in thicker and more diseased tissues. The system also features a low profile jaw for easier placement and maneuverability around surrounding structures. Pre-clinical studies have demonstrated that the ablation lines are consistently transmural in thicker tissues. The Isolator Synergy is a product of AtriCure (Cincinnati, OH, USA) and has been approved by the U.S. Food and Drug Administration (FDA) for the ablation of soft tissue. The device is not yet cleared for the ablation of cardiac tissue.